AIBS 2017
AIBS 2017 was the fourth edition of the Survey. In addition to AIBS’ core questions, the 2017 edition of the Survey featured a special focus on the use
of Australia’s free trade agreements and related issues.
Highlights of the 2017 edition include:
- Around 1,000 Australian businesses were surveyed, 93% of which were involved in exporting, 48% in importing, 23% in other international activities,
and 19% in two-way investment;
- China (23%), the United States (22%) and New Zealand (12%) were the most important markets for respondents, by international revenue;
- Businesses were ambitious in their expansion plans, with three-quarters of survey respondents planning to expand to new markets in the next two years, of which 37% are aiming for 1-3 new markets, 30% for 4-10 new markets, and 6% for 11 or more new markets.
Join Us
Become A Member
Eric Meppem,
Co-Founder & Commercial Director,
Pharmako Biotechnologies Pty Ltd
Member of the ECA
"Pharmako Biotechnologies were already exporting when we joined the ECA. We joined to assist our export strategies, and unashamedly to promote ourselves
through the Australian Export Awards. As a small business, third party recognition and industry membership assist when dealing with large
multinational businesses."
Featured Member
.png?Action=thumbnail&algorithm=fill_proportional&width=262)
Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter
products sold in a growing number of global markets. Contract manufacturing opportunities are also available.